Generix Group Stock

Generix Group ROE

Delisted

The Return on Equity (ROE) of Generix Group (GENX.PA) as of Jul 26, 2026 is 7.39 %. In the previous year, Return on Equity (ROE) was 11.29 % — a change of -34.50% (lower).

ROE

7.39 %

YoY

-34.50%

Last updated:

In 2026, Generix Group's return on equity (ROE) was 7.39 %, a -34.50% increase from the 11.29 % ROE in the previous year.

Access this data via the Eulerpool API

Generix Group Stock analysis

What does Generix Group do? Generix Group SA is a leading provider of software solutions for supply chain management and e-commerce. The company was founded in 1990 in France and has its headquarters in Paris. It employs over 1,000 employees and operates in Europe, North America, and Asia. Its business model is based on the development and sale of software solutions for optimizing supply chains and business processes. They offer a range of products including warehouse management systems, transport management systems, supply chain planning, electronic data interchange, and e-commerce platforms. The company is segmented into three business areas: supply chain collaboration, supply chain execution, and e-commerce. They offer solutions for collaboration between suppliers, customers, and partners, as well as inventory management, transportation, and delivery management. They also have platforms for online sales and distribution that cater to B2B and B2C companies. Some of their key products include collaborative supply chain management, warehouse management, and transportation management. They also develop innovative technologies such as robotic warehouses and cloud platforms for e-commerce. They are pioneers in artificial intelligence and machine learning, working closely with universities and research institutions. Overall, Generix Group SA has a strong position in the supply chain management and e-commerce solutions market, offering a wide range of products tailored to various industries. With their focus on innovation and technology, they are well positioned for future success. Generix Group is one of the most popular companies on Eulerpool.

ROE Details

Decoding Generix Group's Return on Equity (ROE)

Generix Group's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Generix Group's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Generix Group's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Generix Group’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Generix Group stock

Return on Equity (ROE) of Generix Group is 7.39 % in 2026.

Access this data via the Eulerpool API

Profitability — Generix Group

All Key Metrics — Generix Group